Skip to main content
. 2019 May 14;11(5):672. doi: 10.3390/cancers11050672

Table 1.

Expression of cytokines/chemokines in THP-1 cells following treatment with various ODNs. All experiments were performed in four independent replicates, and protein values are presented as mean ± SD. * p < 0.05 (ANOVA, one-way) compared with the MamA2.1 peptide treatment alone.

Cytokines/Chemokines No Pep MamA2.1 MamA2.1 + ODN2006 MamA2.1 + ODN M362 MamA2.1 + ODN2216
Immunostimulatory Cytokines
IL-2 5.2 ± 0.9 6.1 ± 1.2 13.6 ± 2.7 17.2 ± 6.4 7.7 ± 1.4
IL-5 n.d. n.d. 4.9 ± 1.4 6.3 ± 1.9 n.d.
IL-6 157 ± 27 148 ± 23 294 ± 62 * 342 ± 78 * 311 ± 57 *
IL-7 6.1 ± 1.7 5.3 ± 2.2 10.9 ± 3.3 7.2 ± 2.7 6.8 ± 1.3
IL-8 7651 ± 918 8143 ± 1126 13278 ± 1989 14598 ± 1839 10367 ± 772
IL-12p70 163 ± 43 182 ± 31 1672 ± 231 * 1981 ± 161 * 593 ± 49 *
IL-13 2.9 ± 0.6 3.3 ± 1.1 11.9 ± 2.4 14.7 ± 4.3 4.8 ± 1.3
IL-15 n.d. n.d. 7.2 ± 1.9 9.3 ± 3.7 n.d.
Eotaxin 47 ± 16 34 ± 9 59 ± 17 52 ± 18 41 ± 9
IP-10 12 ± 4 14 ± 5 31 ± 9 27 ± 9 21 ± 7
Anti-inflammatory Cytokines
IL-4 n.d. n.d. n.d. 2.9 ± 0.6 n.d.
IL-10 42 ± 12 37 ± 12 19 ± 6 14 ± 6 33 ± 12
IL-1RA 2981 ± 343 2719 ± 469 1516 ± 121 * 1673 ± 131 * 2528 ± 154
Chemoattractants
MCP-1 390 ± 56 422 ± 109 736 ± 152 787 ± 172 496 ± 101
MIP-1α 312 ± 121 431 ± 76 784 ± 112 856 ± 143 533 ± 163
MIP-1β 665 ± 116 726 ± 91 1167 ± 128 1218 ± 109 881 ± 179
RANTES 2139 ± 158 2432 ± 338 7819 ± 911 * 8337 ± 763 * 7917 ± 967 *
Effector Cytokines
TNF-α 598 ± 72 538 ± 69 3871 ± 403 * 5178 ± 476 * 1267 ± 391 *
IFN-γ 127 ± 19 146 ± 21 449 ± 127 503 ± 93 312 ± 72
IL-1β 1439 ± 96 1235 ± 108 1922 ± 216 1822 ± 177 1432 ± 876
IL-17 11 ± 3 14 ± 4 19 ± 4 15 ± 4 16 ± 5
Growth Factors/Cell differentiation factors
IL-9 n.d. n.d. 6.4 ± 2.1 6.1 ± 1.7 3.2 ± 0.8
FGF-basic n.d. n.d. n.d. n.d. n.d.
PDGF-BB 23 ± 8 19 ± 3 27 ± 7 24 ± 8 31 ± 6
VEGF 3415 ± 482 2769 ± 511 5853 ± 721 * 7241 ± 818 * 7471 ± 917 *
G-CSF 456 ± 89 514 ± 132 738 ± 171 674 ± 133 598 ± 123
GM-CSF 31 ± 9 36 ± 8 53 ± 14 44 ± 12 54 ± 16